Episode Details

PSA and DRE screening – to do or not to do, where is the evidence?  And intensive lifestyle changes in early prostate cancer. 

1. Digital rectal examination - recommendations 

2. PSA test– what is it, the benefits and risks, medicare implications, the review of guidelines for screening for average to high risk and follow up, what to do with a + result, age related reference ranges  and the PSA variables – free/total %, double, velocity, PHI, MRI

3. Intensive lifestyle change in early prostate cancer 

References:

Prostate Cancer Foundation of Australia and Cancer Council Australia Expert Advisory Panel – Clinical practice guidelines PSA testing and early management of test detected prostate cancer PSA Testing 2015, http://wiki.cancer.org.au/australia/Guidelines:PSA_Testing

Urological Society of Australia and New Zealand April 2017 statement

http://www.racgp.org.au/your-practice/guidelines/prostate-cancer/

http://www.racgp.org.au/afp/2013/januaryfebruary/prostate-cancer/

https://www.ncbi.nlm.nih.gov/pubmed/16822843

Intensive lifestyle change in prostate cancer, 2005 - https://www.ncbi.nlm.nih.gov/pubmed/16094059

Gene expression changes in intensive lifestyle changes in prostate cancer, 2008 - https://www.ncbi.nlm.nih.gov/pubmed/18559852 

https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/how-diagnosed.html

http://www.snp.com.au/media/305331/item_44879_prostate_cancer_testing_november_2016.pdf

 http://www.sapathology.sa.gov.au/wps/wcm/connect/sa+pathology+internet+content+new/content/news/what+is+psa